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Abstract
Background: COUP-TF interacting protein 2 [(Ctip2), also known as Bcl11b] is an important regulator of skin homeostasis,
and is overexpressed in head and neck cancer. Ctip2
ep2/2 mice, selectively ablated for Ctip2 in epidermal keratinocytes,
exhibited impaired terminal differentiation and delayed epidermal permeability barrier (EPB) establishment during
development, similar to what was observed in Ctip2 null (Ctip2
2/2) mice. Considering that as an important role of Ctip2,
and the fact that molecular networks which underlie cancer progression partially overlap with those responsible for tissue
remodeling, we sought to determine the role of Ctip2 during cutaneous wound healing.
Methodology/Principal Findings: Full thickness excisional wound healing experiments were performed on Ctip2
L2/L2 and
Ctip2
ep2/2 animals per time point and used for harvesting samples for histology, immunohistochemistry (IHC) and
immunoblotting. Results demonstrated inherent defects in proliferation and migration of Ctip2 lacking keratinocytes during
re-epithelialization. Mutant mice exhibited reduced epidermal proliferation, delayed keratinocyte activation, altered cell-cell
adhesion and impaired ECM development. Post wounding, Ctip2
ep2/2 mice wounds displayed lack of E-Cadherin
suppression in the migratory tongue, insufficient expression of alpha smooth muscle actin (alpha SMA) in the dermis, and
robust induction of K8. Importantly, dysregulated expression of several hair follicle (HF) stem cell markers such as K15,
NFATc1, CD133, CD34 and Lrig1 was observed in mutant skin during wound repair.
Conclusions/Significance: Results confirm a cell autonomous role of keratinocytic Ctip2 to modulate cell migration,
proliferation and/or differentiation, and to maintain HF stem cells during cutaneous wounding. Furthermore, Ctip2 in a non-
cell autonomous manner regulated granulation tissue formation and tissue contraction during wound closure.
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Introduction
Cutaneous wound healing is a highly coordinated physiological
process which involves a cross-talk between different cell types such as
keratinocytes, fibroblasts, and immune cells [1,2,3,4]. Upon injury
there is a break in EPB function, and regeneration of the epidermis
post wounding involves activation, migration and proliferation of
keratinocytes from surrounding epidermis and adnexal structures
(HF and sweat gland) [5,6]. Re-epithelialization after epidermal
injury involves resurfacing of the wound with new epithelium thereby
providing rapid restoration of epidermal integrity and barrier
function [7,8,9]. The changes in classic Ca
2+ -dependent cell–cell
adhesion molecules such as E-and/or P-cadherin also play distinct
roles in supply of keratinocytes toward a wound re-epithelialization
[10,11]. Wound repair occurs in the proliferative phase where
fibroblasts provide the collagen framework for dermal regeneration,
and pericytes and endothelial cells together participate in regener-
ation of the outer layer of capillaries in the angiogenic process.
Migration and proliferation at the periphery of the wound are
regulated by various growth factors, integrins, the extracellular
matrix, and other regulatory proteins [8,12].
The mitotically active basal layer of the skin express Keratin 5
(K5) and K14 and the differentiated keratinocytes express K1 and
K10 [13,14]. The activated suprabasal keratinocytes in wound
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express K6, K16 and K17 [14,15,16]. K6 is widely expressed at
the wound edge and over the wound bed [14,17,18,19]. In mouse
skin, K16 is particularly involved in the re-epithelialization process
by affecting migration of keratincoytes [16,20]. K8 and K18 are
the first keratins expressed during embryogenesis but not in the
adult epidermis [7]. Invasive growth and malignancy of both
human and murine epithelial tumors are linked with increased
levels of K8 [21]. Increased expression of K8 has also been linked
to a reduced re-epithelialization efficiency at wound margins [7].
K15, intermediate filament protein, is expressed mainly in the
basal keratinocytes of stratified tissues or slowly turning over basal
cells and also in subset of keratinocytes in the outer root sheath of
HF [22]. The expression of K15 protein is downregulated in
activated keratinocytes of hyperproliferating epidermis such as in
wound bed, psoriasis and hypertrophic scars [4,23].
Epithelialization during wound repair is mainly carried out by
keratinocytes, which play an important role during this process.
After the wound surface is covered by keratinocytes, expression of
integrins and basal keratins by suprabasal cells decreases, leading
to terminal differentiation in the outer layers of unwounded
epidermis [8]. Cutaneous stem cells within the undamaged adult
epidermis reside in the bulge region of the HF, keratinocytes of the
interfollicular epidermis (IFE) and sebaceous glands [24,25,26,27].
Skin wound repair and regeneration after wounding depends on
the long-lived stem cells in the IFE and HF to contribute to re-
epithelialization of wounds in vivo [5,24,28,29,30]. Epithelial stem
cell marker K15 is known to be expressed preferentially in stable
or in basal cells that turn over very slowly, and is more tightly
coupled to a mature basal keratinocyte phenotype [22]. HF stem
cell markers such as Nuclear factor of activated T-cells,
cytoplasmic 1 (NFATc1), CD34 and Prominin-1/CD133 are all
known to contribute in regulating epidermal stem cell quiescence,
location, proliferation, wound healing and in tumor formation
[31,32,33,34,35,36,37]. The stem/progenitor cell marker CD133
is expressed in the specialized mesenchymal cells at the base of the
HF in normal skin [34,38]. K15 and stem/progenitor cell marker
CD133/prominin-1 (CD133) is strongly expressed during cell
expansion of cultured human keratinocytes from skin explants
[39]. 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced HF
stem cell activation and tumor formation in mice requires
CD34. NFATc1 is expressed exclusively in the bulge region of
the HF and both gain- and loss-of function studies demonstrate an
inhibitory role for NFATc1 in stem cell activation in the HF [33].
Chicken ovalbumin upstream promoter transcription factor
(COUP-TF) interacting protein 2 [(Ctip2) is a C2H2 zing finger
transcriptional regulatory protein that regulates transcription by
direct DNA binding activity or by interacting with COUP-TF
nuclear receptor proteins [40,41]. Ctip2 is highly expressed in
mouse skin during development as well as in adult skin [42,43].
Our lab has previously shown that Ctip2 controls epidermal
proliferation/differentiation, formation of EPB, and is a key
regulator of expression of subset of genes involved in those
processes [44]. In a recent study we have shown that CTIP2
expression is upregulated in human head and neck tumors and in
atopic dermatitis [45,46]. Interestingly, Ctip2
ep2/2 mice, selec-
tively ablated for Ctip2 in epidermal keratinocytes, exhibited
impaired terminal differentiation and delayed EPB establishment
during development, similar to what was observed in Ctip2 null
(Ctip2
2/2) mice. Considering that as an important role of Ctip2,
we herein examined the role of Ctip2 in wound healing process. In
the present study, we report that, wound healing in mice with
Ctip2 deletion in the epidermis is delayed due to delayed re-
epithelialization, decreased proliferation and altered expression of
HF stem cell markers. The delay in re-epithelialization is possibly
due to tightly packed epidermis caused by inhibition of loss of cell-




Primary keratinocytes were isolated and cultured using a
modified version of a previously described protocol [47]. Briefly,
a piece of dorsal newborn mice skin was incubated in 2 mg/ml
dispase overnight at 4uC. The epidermal layer was separated from
the dermal layer and incubated in TrypLE Select (Invitrogen,
Carlsbad, CA) for 20 min at RT. Cells were rinsed and plated at a
density of 1.5610
5 cells/cm
2 in keratinocyte culture medium
KCM (EMEM supplemented with 8% chelex-FBS, 10 ng/ml
EGF, 0.05 mM CaCl2,1 6antibiotic and antimicotic). Cells were
grown at 35uC in a humidified 5% CO2 incubator and medium
was changed every 2,3 days.
In vitro scratch assay
An in vitro scratch wound healing assay was done as described
earlier with a slight modification [48]. Briefly, primary mouse
keratinocytes from Ctip2-null mice were grown to about 60,70%
confluence in KCM and part of cells were removed by scratching
the layer with pipette tips. After rinsing detached cells off with PBS
and KCM, cells were incubated at 35uC in a humidified 5% CO2
incubator. Images were captured everyday for 4 days after
wounding using a CCD digital camera MicroPublisher 5.0
(QImaging, Surrey, Canada) connected to a phase contrast
microscope Axiovert 40CFL (Carl Zeiss, Thornwood, NY).
Migration of cells was quantified by measuring and averaging
the distances between the borders of cells at 200 mm intervals in
each captured image using AxioVision version 4.6 (Carl Zeiss)
software. Nine regions were analyzed in each well at each time
point and each genotype, and the result was expressed as the mean
6 SEM. All experiments were performed in the presence of 1 mg
or 5 mg/ml of mitomycin-C to exclude any non-migration
contributors such as increased cell number.
TPA-induced proliferation
Eight-weeks old C57BL6 wild type male mice (n=3) were
shaved thoroughly on the dorsal side. 24 h later, the shaved skin
was topically treated with 10 nmol TPA (Sigma: St.Louis, MO,
USA) in 100 ml 70% ethanol or 70% ethanol alone (vehicle
control) three times every 48 h. After 24 h following the last
treatment, skin was isolated. A portion of the collected skin was
fixed in 4% paraformaldehyde and embedded in paraffin for
histological staining and IHC study. Another portion of the skin
sample was used for Western blot analysis [49].
Retinoic Acid (RA)-induced proliferation
Eight-week old male C57BL6 wild type mice (n=3) were shaved
dorsally and after 24 h, treated four times every 24 h with
40 nmol RA [(in 100 ml 70% ethanol),] or 70% ethanol alone
(vehicle control). 24 h after the final treatment, the treated skin
was isolated for histological and IHC analysis (fixed in 4%
paraformaldehye and embedded in paraffin), and for Western
blotting.
Hair cycle stages
Induction of hair growth by depilation and harvesting skin
samples: In order to synchronize hair cycling, wax depilation was
performed on 6–8-weeks old male C57BL/6 mice on the dorsal
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stage of HF development as confirmed by pink color of the skin
(Day 0), anagen at Day 3, confirmed by skin darkening due to
follicular melanogenesis, catagen at Day 16 and telogene at Day
25 [50,52,53]. The hair on the back of the mouse was carefully
shaved using an electric razor 1 day before taking the skin samples
to allow easier tissue sectioning and observation. The tissue
samples were processed and sectioned to perform Hematoxylin &
Eosin (H&E) staining and IHC [46].
Normal hair cycle: Skin samples from normal hair cycle stages
were collected at post natal days 28 (2
nd anagen) and 49 (2
nd
Telogen) and processed for IHC as described above [54].
Wound healing assay
Mice were kept in standard housing conditions at the satellite
animal facility. ‘‘Animal protocol was approved by Oregon State
University Institutional Animal Care and Use Committee
(IACUC), under permit number 3636’’. For wound-healing
studies, full-thickness excisional wounds, 5 mm in diameter, were
generated on the dorsal side of 6–8 week-old adult female Ctip2
L2/L2
and Ctip2
ep2/2 mice (10 mice per genotype) using a 5 mm
punch biopsy (Miltex Inc, YORK,USA). The wounds were
imaged digitally each day and the diameter of each wound was
measured using Photoshop (version 6.0; Adobe system, San Jose,
CA). Healing was defined as the decrease in wound diameter over
time and was expressed as the percentage of the day 0 wound
diameter. Separate wound healing experiments were performed
on Ctip2
L2/L2 and Ctip2
ep2/2 animals (8 animals of each
genotype) per time and used for harvesting samples for protein
extraction, histology and IHC. Briefly, the complete wound tissue
with 2–3 mm border was excised around the wound at different
time points (days 3, 5, 7, 9, 11 and 13) after injury, were bisected
into two halves, one half immediately frozen for protein
extraction and the other used for histology and IHC. Non
wounded back skin was used as control. Most of the IHC were
done on day 5 samples. Distance of the epithelial tongue
migration from both sides was also measured. Data from
each experiment were pooled. Immunoblot analysis on the skin
extracts of wound healing samples was performed as described
below. Statistical analysis was performed using the unpaired t-test
and ‘‘two-way ANOVA’’ using the GraphPad Prism4 software.
Whole skin extracts preparation and immunoblot
analyses
Skin wound biopsies and samples from tape-stripping assays (at
0, 24 and 48 hours post tape stripping) were homogenized in
Radio-Immunoprecipitation Assay [(RIPA buffer): 50 mM Tris,
pH 7.5, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS,
150 mM NaCl, 5 mM EDTA, proteinase inhibitors] using tissue
grinder and cleared by centrifugation. Supernatants were collected
and equal amounts of protein (25 mg, determined using the
bicinchoninic acid (BCA:Pierce, Rockford, IL) protein assay) were
subjected to SDS-PAGE, electro-blotted to nitrocellulose mem-
branes, and were analyzed by immunoblotting using antibodies
specific for the experiment. ß-actin was used as a loading control in
these experiments. Membranes were blocked in 5% non-fat dry
milk in Tris buffered saline (TBS) –Tween (T) (10 mM Tris–HCl,
pH 7.8, 150 mM NaCl, 0.1% Tween 20), and incubated
overnight with specific antibodies in the blocking buffer and
developed using chemiluminescent substrate (GE Healthcare)
using horseradish peroxidase-coupled secondary antibodies. The
density of the band from the Western blots were quantified by
using Multi Gauge v2.3 gel image analysis software (Fujifilm
Corporation, Tokyo, Japan) and normalized by ß-actin.
BrdU labeling and detection
Briefly, 6–8 weeks old adult mice were injected with 50 mg/g
bodyweight of BrdU and skin biopsies were taken 2 hours after
injection and processed as described [55]. 5 mm thick paraffin
sections were stained with anti-BrdU (Serotech, Raleigh, NC,
1:200) and anti-Ki67 (Abcam, Cambridge, MA,1:500) antibodies
to detect presence of proliferating S phase cells and those in G1, S,
G2 phases of cell cycle, respectively.
Histological analyses
For histological analysis the complete wounds including
epithelial margins were isolated, bisected, fixed overnight in 4%
paraformaldehyde in PBS, and embedded in paraffin. 5 mm thick
paraffin sections were deparaffinized through graded series of
xylene and ethanol, stained with either H &E or processed for
IHC. Fontana–Masson staining was performed using a commer-
cial kit according to the manufacturer’s protocol (American
MasterTech, Lodi, CA) as described [56].
Images were taken using Leica DME microscope and Leica
DFC280 digital camera and analyzed using Leica Application
suite v3.3.0 and Adobe Photoshop CS4.
IHC analyses
IHC was performed on paraffin embedded sections as described
previously [45,46]. In brief, sections were deparaffinized in xylene,
dehydrated through graded alcohols and a 20 minute, 750 W
microwave pretreatment in citrate buffer (pH 6.0), and followed
by treatment with 10% serum for 60 min. to block nonspecific
antibody binding. The slides were then incubated with primary
antibodies (anti-Ctip2, -K6, -K14, -K10, -Loricrin, -Filaggrin, -Ki-
67, -PCNA, K15). Secondary antibody staining was carried out
with a biotin-labeled antibody (Jackson Immuno Research
Laboratories, Inc.) for 2 hrs. at 37uC, followed by incubation
with a streptavidin-biotin horseradish peroxidase complex (Vector
Laboratories, catalog number: SA-5704). Finally, sections were
rinsed with phosphate buffered saline with tween (PBST),
dehydrated through sequential washes in 50%, 70%, 95%, and
100% ethanol and then cleared in xylene. Slides were mounted
with a mixture of Distyrene, a plasticizer, and xylene (DPX) and
allowed to dry overnight. Images were taken as described in above
section (histological analyses). Immunofluorescence studies utilized
three washes with PBST after primary antibody incubation, and
this was followed by incubation with fluorescently-labeled [Cy2
(1:250) or Cy3 (1:500) (Jackson ImmunoResearch)] secondary
antibody for 2 hrs. Nuclei were counterstained with DAPI. Images
were captured at 206 magnification using Leica DMRA
fluorescent microscope and Hamamatsu C4742-95 digital camera
and processed using OpenLab software and Adobe Photoshop
CS4. IHC data was quantified using Adobe Photoshop CS4 and
Image J software, and epidermal thickness was quantified using
Leica One-Suite software. Multiple sections were analyzed from
mice of each genotype and for each time-point, and significance
was determined using a student’s unpaired t-test.
Antibodies
The following antibodies were used for IHC and/or western
blot analysis: anti-Ctip2 (Abcam, 1:300), anti-b-actin (Sigma, St.
Louis, MO, 1:3000), anti-K14 (Covance, Princeton, NJ, 1:1000),
anti-K10 (Covance, 1:1000), anti-Ki67 (Abcam, 1:500), anti-K6
(Abcam, 1: 200), anti K15 (Covance, 1:1000) anti-Loricrin
(Covance, 1:1000), anti-Filaggrin (Covance, 1:1000), anti-CK16
(Abcam, 1:2500), anti K8 (Troma-1; Developmental Studies
Hybridoma Bank, Ames; 1:200), anti-PCNA (Abcam, 1:1500),an-
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Biotechnology, Inc., CA, 1:200), CD34 (Abcam, 1:200),
LRIG1(R&D Systems, Minneapolis, MN, 1:500), CD133 (Abcam,
1:200), E-cadherin (cell signaling, Danvers, MA, 1:200), Phalloidin
(Sigma, 1:1000) and alpha SMA (Abcam 1:100).
Statistical analyses
Statistical significance of differences between different groups
was assessed using two-tailed unpaired t-test and GraphPad Prism
software. A two-way ANOVA analysis was performed for
excisional wound closure data, and Student’s t-test was utilized
to analyze the data for migratory tongue distances, epidermal
thickness and for quantification of Ctip2, BrdU, Ki-67 and PCNA
positive cells in skin. Quantification of Ctip2, Ki67- or PCNA-
positive cells of control and mutant mice was determined by
counting total number of Ki67/PCNA-positive cells, and ex-
pressed as a percentage of DAPI
+ cells. Quantification of alpha
SMA-positive cells in was done using ImageJ (NIH, MD, USA).
The analysis was by estimation of signal intensity of SMA-positive
cells selectively in the granulation region of dermis of the skin
samples, excluding blood vessels. Data obtained from each group
of control and mutant mice for each time point were combined for
calculating the mean data and SEM. All statistical analyses were
independently performed by blinded investigators.
Results
Ctip2 expression is induced in adult mouse skin
epidermis in response to mechanical injury and
wounding
Ctip2 is highly expressed in mouse skin during embryogenesis
and in adult human skin [42,45]. Adult mice skin contains low
levels of Ctip2 compared to embryonic or neonatal skin [42].
CTIP2 has been reported to be overexpressed in human head and
neck cancer and its expression is linked to poorly differentiated
tumor status [46]. Above results and the link between chronic
wounds and cancer, led us to hypothesize that Ctip2 has important
function(s) during adult tissue injury and in wound healing.
Mechanical injury by tape stripping induces transient epidermal
hyperplasia followed by changes in proliferation and differentia-
tion status of the epidermis [44,57]. To this end, we performed
tape stripping and wound healing in wild type adult mice [18]. As
expected, Ctip2 was expressed in the epidermal keratinocytes in
unwounded skin at very low levels (Fig. 1A). Ctip2 expression was
observed to increase after 24 and 48 hours post tape stripping in
wild type mice skin by immunoblotting, and on wounding at 7, 9
and 11 days post wounding compared to unwounded skin (Fig. 1A,
B and C). Analyses of Ctip2 expression by IHC in post-tape
stripped and wound-healing skin biopsies revealed most intense
Ctip2 expression in hyper proliferative epidermis (HE) (Fig. 1F, see
48 hrs. post tape stripped and Day 7 wound healing epithelium)
compared to normal epidermis. Both mitotically dividing epider-
mal basal cells as well as the post-mitotic suprabasal cells expressed
high levels of Ctip2 during and in later phases of cutaneous healing
(Fig. 1F). Percent Ctip2-positive cells was increased in the
epidermis of both tape stripped skin (59.560.5%) and in full-
thickness wounds (day 5: 6564%; day 7: 7764%) compared to the
unwounded skin (41.561.5%; see Fig. 1C). In order to evaluate if
Ctip2 expression is linked to hair cycle stages, we determined
Ctip2 expression in both depilation induced hair cycle and normal
hair cycle in dorsal skin of wild type mice (Fig. 1D, G, E and Fig.
S1 C and D). IHC analysis of depilation induced hair cycle
revealed that mice anagen HFs had predominant expression of
Ctip2 in the proliferative hair germ (indicated by yellow arrows in
Fig. 1G) and epithelia in outer root sheath (ORS) of the HF
(Fig. 1G). Ctip2 expression was significantly reduced in catagen
and telogen phase (Fig. 1E and G). Percentage of intrafollicular
Ctip2 expression was highest in the depilation induced anagen
followed by catagen and telogen (Mean 6 SEM of anagen,
catagen and telogen are: 84.6961.8; 80.1561.0; 74.2161.923)
(Fig. 1D). IHC staining of Ctip2 in normal hair cycle stages 2
nd
anagen (P28) and 2
nd telogen (P49) did not reveal significant
differences in Ctip2 expression in the intra- and extra-follicular
compartments of the skin (Fig. S1, C and D) [54]. Ctip2 expression
was also analyzed in RA and TPA induced proliferative skin. We
observed an increased epidermal thickness with a concomitant
increase in Ki67- positive proliferating keratinocytes in basal and
suprabasal layers but not in Ctip2 expression, suggesting that
Ctip2 is linked with cell proliferation, but is not induced post TPA
or RA treatment (Fig. S1A and B). Overall, these results confirm
that Ctip2 expression is induced post tape stripping, during wound
healing and in anagen phase of induced hair cycle, suggesting a
role of Ctip2 in these processes.
Selective deletion of Ctip2 in epidermal keratinocytes
delays cutaneous wound healing
Epidermal keratinocytes are key players in wound closure and
are required for the re-epithelialization step. In vitro scratch assays
mimic the in vivo wound re-epithelialization process and commonly
used to measure the motility of adherent cells [48]. We therefore
performed scratch migration assay on isolated primary keratino-
cytes from wild type and Ctip2 null neonatal mice skin to
determine function(s) of keratinocytic Ctip2 in wound closure.
Assay was performed in presence of mitomycin-C (MMC) to block
cell proliferation, which enabled further evaluation of Ctip2 effects
on cell migration, while excluding any influence of cell
proliferation [58,59]. Overall, migration of Ctip2 null keratino-
cytes was reduced in comparison to control cells and the difference
became statistically significant (p,0.05) at day 3 (Fig. S2A). MMC
at 1 mg/ml and 5 mg/ml could inhibit cell proliferation. Both
concentration of MMC equally reduced keratinocyte migration
(days 3 and 4) significantly in wild type and mutant keratinocytes
compared to untreated cells (Fig. S2A). Similar results were
obtained by in vitro transwell migration assays (Fig. S2B). Results
from both assays suggested that Ctip2 was necessary for efficient
wound closure.
Since Ctip2-null mice die within 6–8 hours after birth, we
generated Ctip2
ep2/2 mice, in which Ctip2 was selectively deleted
in the epidermis using Cre-loxP strategy and the K14-Cre mice,
for further in vivo analyses [60,61]. The Ctip2
ep2/2 young adult
mice skin had Ctip2 deletion in most of the areas except some
residual staining, which was occasionally detected by IHC but not
by immunoblotting, indicating that constitutively expressed Cre
recombinase induced a strong deletion of Ctip2 in most cells of the
epidermis (Fig. S3 A and B). Proliferation assay using BrdU
labeling revealed increased number of BrdU positive cells in
Ctip2
ep2/2 epidermis (4.99361.1) compared to the control
epidermis (2.48160.8) (Fig. S3 C and D). Similar trend was
observed for other proliferation marker Ki-67 (Ctip2
L2/L2
9.62860.9 and Ctip2
ep2/211.2361.5) by IHC, although the
increase was not statistically significant (P.0.05) (Fig. S3 D).
Histological analyses of dorsal skin biopsies from 6–8 week-old
Ctip2
L2/L2 (control) and Ctip2
ep2/2 (mutant) mice revealed a
significantly increased epidermal thickness in mutants (mutant:
21.060.9 mm; control: 15.061.0 mm) compared to control mice
(Fig. S3E). Epidermal staining for keratinocyte basal cell marker
K14 was more intense in mutants compared to control skin (Fig.
S3F). Furthermore, immunoblot analyses confirmed that mutant
Role of Ctip2 in Cutaneous Wound Healing
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PCNA (Fig. S4A). Although, no significant difference was observed
for expression of early differentiation marker K10 in mutant
epidermis, the late differentiating marker filaggrin and loricrin
were more uniformly expressed in Ctip2
ep2/2 mice (data not
shown). Altogether, these results suggest that lack of Ctip2 in
young adult epidermis alters epidermal homeostasis in unwounded
skin.
We hypothesized that keratinocytic Ctip2 modulate cutaneous
wound healing in a cell-autonomous manner. Therefore, we
Figure 1. Expression of Ctip2 in skin of adult mice following tape stripping (TS), during full thickness wound healing and in hair
cycling. Immunoblot analyses of Ctip2 protein expression in wild type mice skin 24 and 48 hrs post tape stripping (A), and in wound biopsies
obtained at Days 7, 9 and 11 after wounding (B). b-actin is used as control. (C) Bar chart showing an increase in the percentage of Ctip2 positive cells
48 hours post TS and on days 5 & 7 post wounding (*p,0.05). Bar chart showing, percentage of (D) intrafollicular and (E) extrafollicular Ctip2
expressing cells in depilation induced hair cycling in adult mouse skin. Significant (* P,0.05; **P,0.005) increase in Ctip2 expression was observed in
induced anagen compared to telogen and catagen stages (D and E). (F) An overview of Ctip2 localization by immunofluorescence (IF) in the adult
unwounded mice skin, 48 hr after mechanical injury and at day 7 post wounding using anti-Ctip2 antibody. (G) Overview of Ctip2 localization by IF in
depilation induced hair cycle in mice skin. HE-hyperproliferative epithelium; HF-hair follicle; E-epidermis; D-dermis; Bu-bulge; DP-dermal papilla; bu-
bulge. Yellow dotted lines separates the epidermis from dermis (F) and white dotted lines outlines the HF (G). Scale bars: 50 mm (F) and 25 mm (G).
doi:10.1371/journal.pone.0029999.g001
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ep2/2
mice as described in materials and methods section. In the post
wounding days, mutant mice demonstrated significantly more
open areas compared to the wild type counterparts (Fig. 2A and
B). Quantitative analysis of wound diameter revealed significantly
delayed wound healing in Ctip2
ep2/2 mutant mice compared to
Ctip2
L2/L2controls (p,0.001; Fig. 2B). Re-epithelialization effi-
ciency of the wounds was determined by comparing the gaps
between the migratory tongue from both sides in control and the
Ctip2
ep2/2 mutant skin [20,62,63]. Wound re-epithelialization
was delayed in mutants compared to the Ctip2
L2/L2 control mice
as judged by the distance between the migratory tongue
(Ctip2
ep2/2: Mean 6 SEM 787.8626; Ctip2
L2/L2: Mean 6
SEM 431.3620) (Fig. 2C and D). A thin migratory tongue was
visible on both sides of the Ctip2
L2/L2 control wound margin at
day 5, whereas the mutant epidermis had become thicker and
blunted (Fig. 2D). Increased melanocyte proliferation has been
reported in the regenerating wound epidermis of neonatal mice
skin until day 7 post wounding [64,65]. No differences in
pigmentary activity were observed between the control and
mutant skin pre- and post wounding (Days 5 and 7) by Fontana
Masson staining [56,66]; data not shown). Altogether, these results
indicate that loss of Ctip2 in the epidermis delays rate of re-
epithelialization and establish a cell autonomous role of Ctip2 in
keratinocytes during would healing and skin regeneration.
Impaired keratinocyte activation, altered cell proliferation
and delayed onset of differentiation in Ctip2
ep2/2 skin
during wound healing
Upon injury, keratinocytes in suprabasal compartment nearest
to the wound edge become activated, resulting in morphological
changes and induction of marker gene expression [67,68,69].
Activated keratinocyte markers K6 and K16 that are not
expressed in normal epidermis are expressed in migrating
keratinocytes during wound healing and Keratin 8 (K8) is
expressed in simple epithelia and not in intact epidermis or at
wound margins. Day 5 wounds revealed uniform K6 staining
throughout the newly formed migratory tongue and newly formed
epidermis in control Ctip2
L2/L2 but not in Ctip2
ep2/2 mutant
mice (see Fig. 3A, day5). Interestingly, by immunoblot analyses
day 7 wounds showed an induction in K6 and K16 expression in
Ctip2
L2/L2 controls but not in mutant wounds, and that induction
was delayed until day 9 and day 11 in mutant wounds (Fig. 3B).
Although, unwounded mutant skin exhibited an overall higher
expression of K6 and K16 compared to the control skin (Fig. 3B
and Fig. S4A). As reported earlier, K8 was not detected in the
control skin but was clearly detectable in Ctip2
ep2/2 unwounded
skin (Fig. 3C). In Ctip2
L2/L2 controls wounds, induction of K8 was
detected at days 3–7 post wounding (Fig. 3C, no expression in day
0, indicated by *). Whereas in mutant wounds, K8 induction was
much higher and remained elevated in later days post wounding
(Fig. 3C; see day 7). Our present results suggested that mutant skin
exhibit higher and sustained induction of K8 and delayed
keratinocyte activation post wounding.
It is possible that the delay in wound closure in Ctip2
ep2/2 mice
is also due to differences in proliferation at the wound edge or in
the migrating tip of both wounds. Indeed, IHC analyses for PCNA
revealed a significant decrease in the number of proliferating
keratinocytes in mutant epidermis at days 5 and 7 post-wounding
compared to Ctip2
L2/L2 controls skin (Fig. 4A–D). Western
blotting also revealed a modest difference in induction of
proliferation marker PCNA between Ctip2
L2/L2 controls and
mutant skin wounds on post-injury day 7 (Fig. 3B). However,
PCNA expression in Ctip2
ep2/2 skin remained elevated at later
days (day 11) of healing unlike in wild type where its expression
was reduced to the basal level (Fig. 4A). These results suggest that
loss of keratinocytic Ctip2 resulted in a delayed but persistent
induction of proliferative cells in the epithelial tongues during
wound closure.
K10, a marker for cell differentiation, is expressed in all
suprabasal keratinocytes in a graded pattern. K10 expression was
detected in the migratory tongue adjacent to the wound at day 5 in
the Ctip2
L2/L2 controls mice. However, K10 expression was
greatly reduced in the delayed migratory tongue and epidermis
adjacent to the wound of Ctip2
ep2/2mutant mice at all days post-
wounding (Fig. 4B & C). By day 7 post-injury, expression of K10
in newly formed epidermis of control skin was uniform in all the
suprabasal layers (Fig. 4C, left panel), whereas its expression was
discontinuous and not normalized in the neo-epidermis of mutant
mice (Fig. 4C, right panel). Altogether, these results confirm that
Ctip2 mutant skin had reduced proliferation at the migratory
tongue and reduced differentiation of the neo-epidermis. In
addition, it is conceivable that sustained keratinocyte proliferation
observed in Ctip2
ep2/2 epidermis impedes differentiation within
the suprabasal epidermal layer of these mice. Overall, results
suggest an important role of Ctip2 in regulating keratinocyte
activation, proliferation and differentiation during wound repair.
Lack of E-cadherin suppression in the migratory tongue
and insufficient expression of alpha SMA in the dermis of
Ctip2
ep2/2 mice skin during wound repair
Alterations in cell–cell adhesion is a known phenomenon during
re-epithelialization stage of wound healing, and granulation tissue
formation is important for the remodeling phase [11]. Since
Ctip2
ep2/2 mice wounds displayed delay in migration, we
examined expression of E-cadherin as a marker of adherens
junctions and F-actin distribution during wound healing process at
day 5 post wounding. The migratory epithelium of Day 5 Ctip2
L2/
L2 skin wounds exhibited loss of E-cadherin staining in the cell-cell
borders of basal cells compared to the Ctip2
ep2/2 mutant wounds,
where E-cadherins were readily detectable at cell-cell borders and
expression appeared to be stronger (Fig. 5A). In contrast, F-actin
distribution (visualization of actin microfilaments) appeared to be
normal and well organized actin cytoskeleton was similar in both
control and mutant skin as demonstrated by similar expression
pattern of Phalloidin in both genotypes (Fig. 5B). Since alpha SMA
expressing myofibroblast are responsible for development of extra
cellular matrix (ECM) post inflammation during wound healing,
we looked at its expression on day 5 wounds. Interestingly, the day
5 Ctip2
L2/L2 control skin wounds had stronger alpha SMA
expression in the dermis in the granulation tissue (Ctip2
L2/L2
controls: Mean 6 SEM 66.2460.6015) (See Fig. 5 C and D). In
contrast, Ctip2
ep2/2mutant wounds expressed less alpha SMA in
the granulation tissue (Ctip2
ep2/2 mutants: Mean 6 SEM
39.4863.687). Although the alpha SMA positive vessel numbers
were slightly higher in the Ctip2
ep2/2 mutants (Mean6 SEM
17.3362.603) compared to Ctip2
L2/L2 controls (Mean6 SEM
16.0063.606), it was not statistically significant. Altogether, results
suggest altered cell-cell adhesion and impaired ECM development
in healing wounds of Ctip2
ep2/2 mutant mice.
Altered expression of epithelial stem cell markers during
wound healing in mutant mice
Adult stem cells (ASCs) of the skin are source for lost cells during
wound healing and thus are the key players in tissue regeneration.
We therefore looked at the effects of Ctip2 deletion on expression
of various cutaneous stem cell markers such as K15, NAFTc1,
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wounding. In the control wound adjacent epidermis, K15 level
was down regulated as expected, but the mutant wound adjacent
epidermis had patchy expressions of K15 (Fig. 6A). Immunoblot
analyses exhibited an overall reduction in K15 levels after
wounding in both Ctip2
L2/L2 control and Ctip2
ep2/2 mutant
epidermis (Fig. 3C; days 3–7). However, K15 expression was
restored to basal levels earlier (day 11) in wound-adjacent
epidermis of Ctip2
ep2/2 mice, compared to control mice (see
Fig. 3C). Interestingly, all Day 5 wounds had elevated expression
of NFATc1 in the hair HFs of mutant mice compared to control
mice (Fig. 6B). Western blot analyses confirmed that total NFATc1
protein was upregulated post wounding, as multiple bands were
visible due to the presence of different isoforms (Fig. S3F, Fig. S4
Figure 2. Impaired wound healing in skin of adult Ctip2
ep2/2 mice. (A) Macroscopic images of time course of healing of 5 mm full-thickness
excisional wounds. Note, that in Ctip2
L2/L2 mice at day 7, 9 and 11 post-wounding, the wound area was significantly reduced compared to the
Ctip2
ep2/2 mouse. (B) At indicated time points, the diameter of the wound was measured using photography and digital analyses. Data from three
independent experiments (9 Ctip2
L2/L2 mice and 9 Ctip2
ep2/2 mice were used for this study) were pooled. The difference in the rate of wound closure
was statistically significant between two groups (P,0.001). (C) Graph showing increased migratory tongue distances between the two migratory
epithelial tongue on the wound bed from Ctip2
L2/L2 and Ctip2
ep2/2 mice. (*p,0.05). (D) Hematoxylin and Eosin (H & E) stained images of the day 5
and 9 post wounding samples. The black broken brackets in day 5 and day 9 show the outline of the wound area and the migratory tongue distance
(day 5). Hyperproliferative epithelium; E- Epidermis; D-Dermis. Scale bar: 200 mm( D).
doi:10.1371/journal.pone.0029999.g002
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adjacent hair HFs of Ctip2
L2/L2 control mice but its expression
was lacking in wound adjacent mutant HF at day 5 (Fig. 6C).
Western blot analyses also confirmed induction of CD133 at day 5
in control skin, but its induction was delayed until day13 in mutant
skin (Fig. S3F and Fig. S4B). Expression of another stem cell
marker CD34 was modestly reduced in the bulge region of the
mutant HF compared to the control follicles (Fig. 6D). Immuno-
blot analyses showed reduced CD34 induction at day 5 in
Ctip2
ep2/2 mice, and the levels were not normalized up to day 13
(Fig. S3F and Fig. S4B). Interestingly, robust induction of Lrig1
expression was observed in the junctional zone of the mutant HF
compared to control follicles at day 5 and that increase was
maintained until day 13 post wounding (Fig. 6E and Fig. S3F and
Fig. S4B). Altogether, our results confirm aberrant expression
pattern of a subset of cutaneous stem cells markers in mutant skin
during wound healing.
Discussion
To our knowledge, the role of Ctip2 in regulating the steps of
injury abrasion and wound healing has not been previously
reported. Ctip2 is linked with cell proliferation, its expression
increases proportionately with increase in cell number but is not
induced post TPA or RA treatment. Ctip2 levels also changes with
induced hair cycle, with highest increase in anagen phase and
lowest in catagen phase, possibly regulating hair cycling. Ctip2 is
induced in transient epidermal hyperplasia induced by mechanical
injury, suggesting its importance in adult mice skin when cells
undergo rapid turnover. Similar CTIP2 upregulation has been
reported in epidermis of hyperproliferative diseases such as atopic
dermatitis (AD) and allergic contact dermatitis (ACD) [45],
supporting our assumption that Ctip2 function is implicated in
epidermal regeneration and re-establishment of skin homeostasis
under pathological conditions. We expected to see epidermal
hypoplasia in absence of Ctip2 in Ctip2
ep2/2 mice, instead, we
observed a compensatory hyperplasia in unwounded skin of these
mice, which could be attributed to impaired development of
protective epidermal barrier, and enhanced trans-epidermal water
loss (TEWL) [our unpublished data; [44]]. The effects of Ctip2
deletion was analyzed in in-vivo full-thickness wound-healing
processes and the results suggest defects in proliferation, migration,
cell-cell contacts and proper expression of HF stem cell markers.
The delayed wound re-epithelialization and blunted migratory
tongue observed during wound healing in Ctip2
ep2/2 mice can be
explained in a number of ways. The hyperthickened epidermis at
the wound-edge in the mutants at day 5 indicated keratinocyte
proliferation without sufficient migration. We observed lower
percentages of PCNA positive keratinocytes on days 5 and 7 post-
wounding in the mutants during the early phases of wound healing
process and sustained proliferation in the later days of healing. In
spite of the observed delay in re-epithelialization, eventually these
keratinocytes finally migrated over the wound bed to complete re-
epithelialization, suggesting that mutant keratinocytes must be
lacking factor(s), such as heparin binding epidermal growth factor
(HbEGF), which can stimulate keratinocyte migration during
wound healing [70,71]. We reported earlier that skin of Ctip2 null
mice expressed less HbEGF than control mice skin, thus,
Figure 3. Altered keratinocyte activation (K6 & K16), proliferation (PCNA), differentiation (K10 & K8), and impaired expression of
epithelial stem cell marker (K15) during wound healing in mutant mice. (A) IHC analysis of K6 (red) expression on Day 5 post wounding
samples from Ctip2
L2/L2 and Ctip2
ep2/2 mice. The white dotted lines indicate the migratory tongue on the wound bed (Day5 samples) and separation
of the epidermis from dermis in (A). All sections were counterstained with DAPI (blue). HE- hyperproliferative epithelium; E- epidermis; D- dermis; HF-
hair follicle. Scale bar: 50 mm. (B) Immunoblot analyses of PCNA, K10, K6 and K16 in adult skin of Ctip2
L2/L2 and Ctip2
ep2/2 mice after wounding (Day
7, Day 9 and Day 11). (C) Immunoblot analyses of keratin markers, K8 and K15 induction in the skin of Ctip2
L2/L2 and Ctip2
ep2/2 adult mice on days 3,
5, 7, 9 & 11 post wounding. * indicates undetectable K8 expression in the unwounded wild type skin (day 0). b-actin is used as an internal control.
doi:10.1371/journal.pone.0029999.g003
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to defective autocrine/paracrine EGF signaling pathway [44]. It
seems likely that other factors eventually compensate for lack of
Ctip2, and complete the migration process. The ability of Ctip2 to
regulate other signaling pathways, such as that involving AP-1
[44], could also be responsible for defects in wound closure
[70,71]. We have observed Ctip1 induction in the mutant mice
post injury which might be compensating for loss of Ctip2 and
helping the re-epithelialization process later during healing (data
not shown). In order to be able to migrate, keratinocytes undergo a
preparative phase for re-epithelialization, which is accompanied
by alteration of the cell-cell adhesion mediated by E- and/or P-
cadherin [11]. Down regulation of E-cadherin expression has been
associated to migration of cancer cells and during wound re-
Figure 4. Reduced epidermal proliferation and differentiation in skin wounds from Ctip2
ep2/2 mice. (A–C) Expression of PCNA in skin
sections from Ctip2
L2/L2 and Ctip2
ep2/2 mice on day 5 (A and B) and day 7(C) post wounding, using antibodies against PCNA (in red). (B &C) Co-
localization of K10 and PCNA on days 5 and 7 wound biopsies from dorsal skin of Ctip2
L2/L2 and Ctip2
ep2/2 mice using anti-K10 antibody (green) and
PCNA (red). All slides were counterstained with DAPI. The white arrow points to the directions of the wound (A). Yellow arrow with dotted lines
indicates the direction of wound (B) and separates the epidermis from the dermis (C). MT-migratory tongue; HE- hyperproliferative epithelium; HF-
hair follicle; E-epidermis and D- dermis. (D) Bar graph showing significant decrease (*P,0.05) in percentage of PCNA positive cells during wound
healing on day 5 and 7 in the skin of Ctip2
ep2/2 mice. Green and red bars represent Ctip2
L2/L2 and Ctip2
ep2/2 mice, respectively. Scale bars: 50 mm
(A), 100 mm (B and C).
doi:10.1371/journal.pone.0029999.g004
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ep2/2 mutant day 5 skin wounds. (A) Expression of E-
Cadherin is down regulated in the Ctip2
L2/L2 control basal layer migratory tongue but not in Ctip2
ep2/2 mutants. The insets are magnified. (B)
Expression of Phalloidin (red) is down regulated in the Ctip2
L2/L2 control but not in Ctip2
ep2/2 mutant migratory tongue. (C) Reduced accumulation
of myofibroblast (alpha SMA: red) in Ctip2
ep2/2 mice wounds compared to the wild type mice. (D) Quantification of alpha SMA. Bar graph shows
reduced pixel intensities in Ctip2
ep2/2 compared to the Ctip2
L2/L2 control. Data are represented as means 6 SD. Significant differences between
Ctip2
L2/L2 and Ctip2
ep2/2 (P,0.05). (E) Increased numbers of blood vessels in Day 5 post wounding samples inCtip2
L2/L2 compared to Ctip2
ep2/2
mice but not significant. Values are the mean and SEM (n=4 mice). MT-migratory tongue; E-epidermis and D- dermis. Arrows point to the directions
of the wound. Dotted lines demarcate the epidermis from the dermis. Scale bars: 50 mm (A and B), 100 mm (C).
doi:10.1371/journal.pone.0029999.g005
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ep2/2 mice skin during wound repair. IHC analysis of (A) K15, (B)
NFATc1 (red), (C) CD133 and (D) CD34 and (E) Lirg1 expression in HF on day 5 post wound healing samples from Ctip2
L2/L2 and Ctip2
ep2/2 mice,
using specific antibodies (* indicates loss of CD133 positive cells). The yellow dotted lines indicate the separation of epidermis from dermis near the
wound bed (Day5 samples) in (A) and white dotted lines outline the HF. All sections were counterstained with DAPI (blue). Arrow heads indicate K15
positive cells (A). HE-hyperproliferative epithelium; E- epidermis; D- dermis; HF- Hair follicle; Bu-Bulge; JZ-junctional zone. Scale bars: 50 mm.
doi:10.1371/journal.pone.0029999.g006
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the basal layer of epidermis in the wound margin keratinocytes
during wound repair processes [10,11]. In agreement with
previous report, we observed it’s down regulation in the wound
margin keratinocytes in control mice but not in the mutant
wounds. Our results suggest that cell-cell contact appear tighter in
the mutants when compared to loosely packed cells in the control
wounds, thereby inhibiting keratinocyte migration and re-
epithelialization. Similar observations were also reported in b1-
integrin null mice having keratinocytes with impaired migration
and tightly packed hyperproliferative epithelium [72]. Interesting-
ly, E-Cadherin suppression has been reported to direct cytoskeletal
rearrangement and intraepithelial tumor cell migration in 3D
human skin equivalents [10].
Normal differentiation after wound healing is marked by
restoration of expression of differentiation markers (K10, loricrin
and involucrin) in the neo-epidermis. Reduced expression of K10
in the mutant neo-epidermis suggested a delay in restoration of the
normal differentiation program. K10 expression is lowest at the
wound edge and increasingly higher levels of K10 are expressed
radiating out from the wound edge [67,73]. Expression of
differentiation markers K10 and filaggrin was also strongly
reduced in Ctip2
2/2 neonatal mice, which affected the differen-
tiation program [44]. Wounds in Ctip2
ep2/2 mutants exhibited a
delayed K6 induction and a delay in K15 suppression, leading to
an overall delay in activation, and hence a slower rate of cell
migration and re-epithelialization. During wound healing, K6,
K16 and K15 are differentially expressed. K15 expression is
repressed during the first few days of wound healing whereas K6
and K16 expression increases in the same time window [74]. One
of the important features of hyperproliferative healing epidermis is
the induction of K6 during wound healing [3,32,72]. In the
present study, K6 and K16 induction occurs much later in the
wound-healing process in Ctip2
ep2/2 mutants compared to the
control mice. Reduced K6 expression has been linked to delay in
wound healing in transgenic mice overexpressing stem cell marker
Necl2 [32]. Patches of K15 expression were also detected in the
wound bed at day 5 post wounding in mutants, suggesting that
these keratinocytes were less activated (confirmed by low K6
expression in the same cells). Such premature expression of K15
indicates a degree of early maturation of basal cells [22]. It is
possible that although the mutant epidermis proliferated appro-
priately, the timing of expression of keratin markers K6 and K15
in mutant keratinocytes was out of phase resulting in a delay in
wound closure [18,74]. Suppression of K15 expression by growth
factors and cytokines has been reported from both in vitro and in
vivo cutaneous injury studies [74].
Interestingly, robust induction of K8 expression in Ctip2
ep2/2
mutant epidermis is indicative of faulty K8 regulation, and
disruption of epidermal differentiation program. Elevated K8
expression is associated with increased migration and invasive
capacities in some situations [75,76,77]. Sporadic expression of K8
in HF has been reported earlier and could explain the induction of
this gene by wounding in the wild type mouse skin [21]. Alteration
in morphology and differentiation of epidermis and HFs was seen in
mice over-expressing human K8 in the skin [21]. Increased
expression of K8 in Slug mutant mice lead to compromised re-
epithelialization similar to Ctip2 mutant mice, suggesting that
elevated K8 may not support re-epithelialization [7]. Interestingly,
Sluglevel wasunaltered in skin of Ctip2 mutant mice and Ctip2 was
not recruited on K8 promoter region suggesting a yet unidentified
mechanism(s) of its regulation by Ctip2 (data not shown).
Furthermore, myofibroblasts are required in normal wound
healing for wound contraction and ECM formation. Ctip2 is
highly expressed in dermal fibroblasts during skin organogenesis
and Ctip2 expression is induced in the dermis during cutaneous
wound healing, suggesting that this transcription factor might play
a role in dermal homeostasis or response to wounding. Presence of
aSMA-positive myofibroblasts both in the Ctip2
L2/L2 and
Ctip2
ep2/2 mutants wounds corroborates well with previously
published results [78,79]. However, reduction of myofibroblast
differentiation (confirmed by low expression of alpha SMA) in the
granulation tissue of healing wounds from Ctip2
ep2/2 mutant
mice at day 5 post wounding suggests that, although the
myofibroblast cells are recruited in the healing process they are
not sufficient enough for normal healing. Our results indicate a
non-cell autonomous role of keratinocytic Ctip2 in mediating
myofibroblast differentiation. Therefore, actual contribution of
Ctip2 in dermal fibroblasts during wound healing might need to
be delineated following selective ablation of Ctip2 in this cell
compartment using specific Cre-deletor strains.
Most importantly, we have seen that several cutaneous stem cell
markers (K15, NFATc1, CD34 and CD133) were aberrantly
expressed during wound healing in Ctip2
ep2/2 mice. Keratino-
cytes that re-epithelialize the wound are derived from interfollic-
ular epithelial stem cells (epiSC) and from the hair bulge, and
Ctip2 is expressed in both compartments. We have previously
shown that Ctip2 co-localizes with most of the CD34 expressing
cells in HF. In this study, we have shown that post wounding, day
5 epidermis in Ctip2
ep2/2 mice (lacking Ctip2 in epidermis) has
low levels of CD34 in wound adjacent HF suggesting lack of
sufficient availability of CD34 positive cells for the normal healing
of the mutant skin [42]. It has been shown that co-transplantation
of CD34(+) cells with CD34(+) endothelial cells improved wound
healing [80]. Therefore, absence of CD34+ cell population in
mutants could be one of the factors for delayed healing. In an
improved method of human keratinocyte culture from skin
explants, cells that migrated out from explants strongly expressed
markers K15 and CD133 and displayed intense K6 expression,
indicative of activated keratinocytes in wound-healing epidermis
[39]. Therefore, lack of CD133 positive cells in the Ctip2 mutant
skin HF can contribute, at least in part, to delayed re-
epithelialization and wound closure. Stem cell marker NFATc1
is expressed by quiescent adult stem cells of the HF. Suppression of
NFATc1 signaling pharmacologically or by conditional NFATc1
gene ablation, activated stem cells prematurely, resulting in
premature follicular growth [33]. In our study, parallel NFATc1
induction was noted in mutant mice at post wounding day 5,
suggesting less activation of stem cell population available to re-
populate the wound bed. Similarly, Lrig1 overexpression has been
shown to have growth inhibitory effects by inhibiting ERK
activation and cell cycle progression. During development as well
as in postnatal stages, epidermal growth factor receptor (EGFR)
signaling controls important cellular programs such as survival,
proliferation and differentiation. Lrig1 is one of the inducible
feedback inhibitors (IFIs) that bind to EGFR and suppress receptor
signaling through several mechanisms [81,82]. We observed
modest increase in Lrig1 expression in the unwounded skin of
mutant mice, and these mice had robust induction of Lrig1 post
wounding day 5. Interestingly, Ctip2 null keratincytes express low
levels of EGFR (Zhang et al., unpublished data). EGFR has been
implicated in the regulating multiple facets of wound healing
including proliferation, migration and wound contraction [83].
Therefore, loss of EGFR can explain, at least in part, the delay
observed in cutaneous wound healing in Ctip2
ep2/2 mice.
Altogether, altered expression of many of the HF stem markers
were observed in these mice and leaves a potential scope for future
studies on how Ctip2 regulates stem cell mobilization during post
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ment(s) using individual stem cell lineage specific Cre-driver mice.
In conclusion, our current studies suggest that Ctip2 in
keratinocytes might be an important player in wound repair
processes in otherwise healthy patients, as well as those with
chronic diseases, such as diabetes. A more complete understanding
of contribution of Ctip2 mediated regulatory controls of cutaneous
stem cells, inflammation and hair cycling during wound healing is
necessary for better control of wound repair and tissue
regeneration. Understanding the mechanisms of Ctip2 mediated
regulation of tissue remodeling is likely to provide novel treatment
strategies for improved wound healing.
Supporting Information
Figure S1 Ctip2 expression in TPA & RA induced skin
hyperproliferation and in different stages of hair
cycling. (A) Immunoflourescence staining of Ctip2 (red) and
Ki-67 (green) in TPA and RA treated skin of the wild type mice.
All slides were counterstained with DAPI (blue). The yellow dotted
lines indicate separation of the epidermis from dermis. (B)
Quantification of epidermal Ctip2 and Ki-67 in TPA and RA
treated wild type skin. # indicates that the Ctip2 percentages are
not significant between the treatment groups. * indicates that the
Ki-67 percentages are significant between the groups (p,005).(C)
Immunoflourescence staining of Ctip2 (red) in skin of wild type
mice during normal hair cycle stages 2
nd anagen and 2
nd Telogen.
(D) Quantification of extrafollicular and intrafollicular Ctip2+ cells
during natural hair cycle stages do not show significant difference
in their expression pattern. Scale bars: 50 mm (A), 100 mm (C).
(EPS)
Figure S2 Reduced migration of Ctip2
2/2 keratinocytes
in in vitro scratch migration and transwell migration
assay. Scratch migration assay in keratinocytes were performed
in presence of 1 mg/ml and 5 mg/ml of MMC. After scratches
were introduced, cell migration and wound closure were
monitored at indicated times (Day 0, 1, 2, 3 and 4). For transwell
assay, keratinocytes were seeded at a density of 3610
5 cells/cm
2
into the upper wells of transwell inserts. After one or two days cells
in the upper wells were removed by cotton tip swabs, and cells on
the lower surface of the membrane were fixed in methanol and
stained with DAPI. (A) Graph representing significant (*P,0.01)
decrease in migration of mutant keratincoytes in presence of
MMC compared to the wild type, at days 2 and 4 after scratching.
The width of the cell free area was measured and the calculated
migration distance was plotted against days. The values are mean
6 SEM. (B) Graphical representation of motility of Ctip2
knockout keratinocytes presented as percent of wild type cells
determined by transwell assay.
(EPS)
Figure S3 Characterization of adult Ctip2
ep2/2 mice
skin and expression of stem cell markers. (A) Immuno-
staining of Ctip2 (red) in 4 weeks old Ctip2
ep2/2 mice dorsal skin.
(B) Immunoblot analyses of Ctip2 protein expression in Ctip2
L2/L2
and Ctip2
ep2/2mice dorsal skin. b-actin is used as an internal
control. (C) Immunostaining for BrdU (green) and Ki-67 (in red) in
skin from Ctip2
L2/L2 and Ctip2
ep2/2 adult mice. (D) Quantifi-
cation of epidermal BrdU and Ki-67 positive cells in the skin did
not reveal significant difference between wild type and control
(indicated by # P.0.05). (E) Quantification of epidermal
thickness. Significant (*P,0.05) increase in epidermal thickness
in Ctip2
ep2/2 compared to Ctip2
L2/L2 mice. (F) Immunostaining
for Keratin 14 (red) on Ctip2
L2/L2 and Ctip2
ep2/2 adult mice
skin. All sections (A, C and E) were counterstained with DAPI
(blue). Yellow dotted yellow lines demarcate the epidermis from
dermis (A). E- epidermis, D- dermis. HF-Hair follicle. Scale bar:
50 mm (A-C-D).
(EPS)
Figure S4 Quantification of proliferation, differentia-
tion and kertainocyte activation and stem cell markers
in control and mutant skin. (A) Protein levels of PCNA, K10,
K6, K16 and K15 were quantified by densitometric analyses of
western blots performed on control and mutant skin at days 3, 5, 7,
9 and 11 post wounding. All data were normalized for ß-actin
levels. (B) Quantification of the protein level of stem cell markers,
Lrig1 and NFATc1 at days 5,9 and 11 post wounding as
determined by densitometry analyses of Western blots. All data
was normalized by the corresponding ß-actin levels.
(EPS)
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